...
首页> 外文期刊>The Journal of Nuclear Medicine >Radioimmunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA x anti-DTPA-indium bispecific antibody.
【24h】

Radioimmunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA x anti-DTPA-indium bispecific antibody.

机译:使用111价铟半价半抗原和抗CEA x抗DTPA价铟双特异性抗体对甲状腺髓样癌进行放射免疫检测。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Pretargeting labeled bivalent hapten with bispecific antibodies has proven feasible in the clinic, and our earlier results have suggested the technique may be very sensitive for detecting small recurrences and metastases. Medullary thyroid carcinoma (MTC) is an example where this technique may be the most useful since local recurrences and isolated metastases are removed surgically when detected, and thyrocalcitonin provides a specific and sensitive tumor marker. In our current study, we evaluated pretargeted immunoscintigraphy in a larger number of MTC patients. METHODS: Anti-carcinoembryonic antigen (CEA) x anti-diethylenetriaminepentaacetic acid (DTPA) indium bispecific antibody and 111In-labeled bivalent DTPA hapten were administered sequentially (4-5 days apart) to 44 patients with elevated circulating calcitonin after resection of primary MTC. Immunoscintigraphy was performed 2, 5 and 24 hr after hapten injection and, when necessary, at longer time intervals. When available, a handheld gamma probe was used during surgery. RESULTS: Fifteen patients had known tumor sites before immunoscintigraphy. Tumors were imaged in 12 (80%) of these patients, including 3 with liver metastases. Five unknown tumor sites were detected. For the 29 patients with occult disease, immunoscintigraphy detected high-activity uptake sites in 21 patients (72%), including 5 in the liver. Twelve were confirmed by surgery, 1 by guided morphologic imaging and 1 by venous catheterization. There were 2 false-positive patients. The other 5 patients have not yet been confirmed. All detected liver metastases were high-activity uptake areas. Radioimmunoguided surgery was used in 14 patients. It was considered helpful by the surgeon in 12 patients, including 4 patients where it determined the resection of small, not palpable nor visible, tumor-involved lymph nodes. Surgical resection resulted in a significant decrease (8 patients) or normalization (1 patient) of circulating calcitonin and CEA. CONCLUSION: This technique affords high sensitivity and specificity for detecting small tumor lesions including liver metastases. Its use for immunoscintigraphy and guided surgery should improve the therapeutic management of recurrent MTC.
机译:在临床上已证明用双特异性抗体预标记带标记的二价半抗原是可行的,我们的早期结果表明该技术对于检测小的复发和转移可能非常敏感。甲状腺髓样癌(MTC)就是这种技术最有用的一个例子,因为当检测到局部复发和孤立的转移灶时,可通过手术将其去除,而甲状腺降钙素提供了特异性和敏感的肿瘤标志物。在我们目前的研究中,我们评估了许多MTC患者的预靶向免疫闪烁扫描。方法:对44例初次MTC切除后循环降钙素升高的患者依次(间隔4-5天)给予抗癌胚抗原(CEA)x抗二亚乙基三胺五乙酸(DTPA)铟双特异性抗体和111In标记的二价DTPA半抗原。在半抗原注射后第2、5和24小时进行免疫显像,必要时间隔更长的时间。如果有的话,在手术期间使用手持式伽马探针。结果:15例患者在免疫闪烁扫描之前就已经知道了肿瘤部位。这些患者中有12名(80%)肿瘤成像,其中3名有肝转移。检测到五个未知的肿瘤部位。对于29名隐匿性疾病患者,免疫闪烁显像法在21名患者(72%)中检测到高活性摄取位点,包括肝脏中的5个。通过手术确认了十二个,通过引导性形态学成像确认了一个,通过静脉导管检查确认了一个。有2例假阳性患者。其他5例患者尚未确认。所有检测到的肝转移均为高活性摄取区域。放射免疫引导手术用于14例患者。外科医生认为这对12例患者有帮助,其中包括4例决定切除肿瘤相关的小,不明显或不可见的淋巴结的患者。手术切除导致循环降钙素和CEA显着减少(8例)或正常化(1例)。结论:该技术为检测包括肝转移在内的小肿瘤病变提供了高灵敏度和特异性。将其用于免疫闪烁扫描和引导性手术应改善复发性MTC的治疗管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号